{"id":50250,"date":"2022-10-31T09:03:48","date_gmt":"2022-10-31T08:03:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/"},"modified":"2022-10-31T09:03:48","modified_gmt":"2022-10-31T08:03:48","slug":"ochre-bio-announces-participation-in-upcoming-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/","title":{"rendered":"Ochre Bio Announces Participation in Upcoming Conferences"},"content":{"rendered":"<div>\n<p>OXFORD, England&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/chronic?src=hash\" target=\"_blank\" rel=\"noopener\">#chronic<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ochre-bio.com%2F&amp;esheet=52954975&amp;newsitemid=20221031005044&amp;lan=en-US&amp;anchor=Ochre+Bio&amp;index=1&amp;md5=ac14b6bbb320d21d35239620b1d1eae0\" rel=\"nofollow noopener\" shape=\"rect\">Ochre Bio<\/a>, an innovator in chronic liver disease drug development, today announced its participation in upcoming investor and industry conferences.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221031005044\/en\/1617359\/5\/ochre_bio_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221031005044\/en\/1617359\/21\/ochre_bio_logo.jpg\"><\/a><\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwebsummit.com%2F&amp;esheet=52954975&amp;newsitemid=20221031005044&amp;lan=en-US&amp;anchor=WebSummit&amp;index=2&amp;md5=ccfdbb71bca32258a17a881f4a286312\" rel=\"nofollow noopener\" shape=\"rect\"><b>WebSummit<\/b><\/a><b><br \/><\/b>Presentation Title: Why you should love your liver<br \/>\n<br \/>Date\/Time: Nov 4, 1:36 WET &#8211; 1:47 pm Western European Time<br \/>\n<br \/>Location: The Altice Arena and FIL, Rossio dos Olivais, 1990-231 Lisbon, Portugal<br \/>\n<br \/>Presenter: Jack O\u2019Meara, CEO &amp; Co-Founder, Ochre Bio\n<\/p>\n<p>\n<b>Big Data and AI Innovation in Drug Discovery<br \/>\n<br \/><\/b>Artificial Intelligence (AI) and big data approaches in drug discovery have gained substantial momentum over the past few years, with the benefit of speeding up drug development timelines as well as reducing research costs. Ochre Bio employs genomics-led target discovery and human-based preclinical models and RNA medicine to develop new therapies for chronic liver diseases. Seeing the infinite potential of AI and big data&#8217;s involvement in drug development, Ochre Bio will hold a symposium in Taipei, Taiwan on this trending topic.\n<\/p>\n<p>\nDate\/Time: Wednesday, Nov. 9, 9:30-12:15 pm<br \/>\n<br \/>Location: 2nd Floor, Building C, National Biotechnology Research Park , No. 99, Lane 130, Section 1, Institute Road, Nangang District, Taipei, Taiwan<br \/>\n<br \/>Symposia Information: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fgeneonline.news%2Fochre-bio-ai-big-data-symposium%2F&amp;esheet=52954975&amp;newsitemid=20221031005044&amp;lan=en-US&amp;anchor=https%3A%2F%2Fgeneonline.news%2Fochre-bio-ai-big-data-symposium%2F&amp;index=3&amp;md5=57747f747cb329073c5cd193ca6c69ff\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/geneonline.news\/ochre-bio-ai-big-data-symposium\/<\/a><br \/>Agenda and registration: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fforms.gle%2FgQeiQaPbexY7ACqy9&amp;esheet=52954975&amp;newsitemid=20221031005044&amp;lan=en-US&amp;anchor=https%3A%2F%2Fforms.gle%2FgQeiQaPbexY7ACqy9&amp;index=4&amp;md5=09dfc5aa3beedd216233a449281e0a8e\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/forms.gle\/gQeiQaPbexY7ACqy9<\/a>\n<\/p>\n<p>\nSpeakers include industry leaders in the field of big data, genomics and drug development:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nDr. Quin Wills, CSO of Ochre Bio\n<\/li>\n<li>\nDr. Jimmy Lin, CEO of Insilico Medicine Taiwan\n<\/li>\n<li>\nDr. Inca Chen, RD Manager of Acer\n<\/li>\n<li>\nProf Liao, CEO of Syncell\n<\/li>\n<\/ul>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.lsxleaders.com%2Finvestival-showcase&amp;esheet=52954975&amp;newsitemid=20221031005044&amp;lan=en-US&amp;anchor=LSX+Inv%26%238364%3B%24tival+Showcase&amp;index=5&amp;md5=5d664b22507073d96afae90c1593bd5f\" rel=\"nofollow noopener\" shape=\"rect\"><b>LSX Inv\u20ac$tival Showcase<\/b><\/a><b><br \/><\/b>Date: Monday, Nov. 14, 10:45 am &#8211; 11:00 am UK time<br \/>\n<br \/>Location: 1 Old Billingsgate Walk, London, UK<br \/>\n<br \/>Presenter: Jack O\u2019Meara, CEO &amp; Co-Founder, Ochre Bio\n<\/p>\n<p>\n<b>Jefferies London Healthcare Conference<br \/>\n<br \/><\/b>Date: November 15-17, 2022<br \/>\n<br \/>Location: Waldorf Hilton (Aldwych), London, UK<br \/>\n<br \/>To meet with the Ochre Bio team at these events, <a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;:&#x63;&#111;&#x6e;&#116;a&#x63;&#116;&#x40;&#111;c&#x68;r&#x65;&#45;&#x62;&#x69;o&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#99;&#111;&#x6e;&#x74;&#97;&#99;&#x74;&#x40;&#111;&#99;&#x68;&#x72;&#101;&#45;&#x62;&#x69;&#111;&#46;&#x63;&#x6f;&#109;<\/a>.\n<\/p>\n<p>\n<b>About Ochre Bio<br \/>\n<br \/><\/b>Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ochre-bio.com&amp;esheet=52954975&amp;newsitemid=20221031005044&amp;lan=en-US&amp;anchor=www.ochre-bio.com&amp;index=6&amp;md5=8aa57af0fae8965171ac2437260be571\" rel=\"nofollow noopener\" shape=\"rect\">www.ochre-bio.com<\/a>. Follow us on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FOchreBio%3Fref_src%3Dtwsrc%255Egoogle%257Ctwcamp%255Eserp%257Ctwgr%255Eauthor&amp;esheet=52954975&amp;newsitemid=20221031005044&amp;lan=en-US&amp;anchor=Twitter&amp;index=7&amp;md5=8ded27b39a3be71f599c12055cac36f0\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a> @OchreBio.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMedia<br \/>\n<br \/>Kimberly Ha<br \/>\n<br \/>KKH Advisors<br \/>\n<br \/>917-291-5744<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#x74;&#111;:&#x6b;&#x69;&#109;b&#x65;&#114;l&#x79;&#x2e;&#104;a&#x40;&#x6b;&#107;h&#x61;&#100;&#118;&#x69;&#x73;&#111;r&#x73;&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">k&#105;&#109;&#x62;&#x65;rl&#121;&#46;&#x68;&#x61;&#64;k&#107;&#104;&#x61;&#x64;vi&#115;&#x6f;&#x72;&#x73;&#46;&#99;&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>OXFORD, England&#8211;(BUSINESS WIRE)&#8211;#chronic&#8212;Ochre Bio, an innovator in chronic liver disease drug development, today announced its participation in upcoming investor and industry conferences. WebSummitPresentation Title: Why you should love your liver Date\/Time: Nov 4, 1:36 WET &#8211; 1:47 pm Western European Time Location: The Altice Arena and FIL, Rossio dos Olivais, 1990-231 Lisbon, Portugal Presenter: Jack &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50250","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ochre Bio Announces Participation in Upcoming Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ochre Bio Announces Participation in Upcoming Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"OXFORD, England&#8211;(BUSINESS WIRE)&#8211;#chronic&#8212;Ochre Bio, an innovator in chronic liver disease drug development, today announced its participation in upcoming investor and industry conferences. WebSummitPresentation Title: Why you should love your liver Date\/Time: Nov 4, 1:36 WET &#8211; 1:47 pm Western European Time Location: The Altice Arena and FIL, Rossio dos Olivais, 1990-231 Lisbon, Portugal Presenter: Jack ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-31T08:03:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221031005044\/en\/1617359\/21\/ochre_bio_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Ochre Bio Announces Participation in Upcoming Conferences\",\"datePublished\":\"2022-10-31T08:03:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/\"},\"wordCount\":368,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005044\\\/en\\\/1617359\\\/21\\\/ochre_bio_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/\",\"name\":\"Ochre Bio Announces Participation in Upcoming Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005044\\\/en\\\/1617359\\\/21\\\/ochre_bio_logo.jpg\",\"datePublished\":\"2022-10-31T08:03:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005044\\\/en\\\/1617359\\\/21\\\/ochre_bio_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005044\\\/en\\\/1617359\\\/21\\\/ochre_bio_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ochre-bio-announces-participation-in-upcoming-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ochre Bio Announces Participation in Upcoming Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ochre Bio Announces Participation in Upcoming Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Ochre Bio Announces Participation in Upcoming Conferences - Pharma Trend","og_description":"OXFORD, England&#8211;(BUSINESS WIRE)&#8211;#chronic&#8212;Ochre Bio, an innovator in chronic liver disease drug development, today announced its participation in upcoming investor and industry conferences. WebSummitPresentation Title: Why you should love your liver Date\/Time: Nov 4, 1:36 WET &#8211; 1:47 pm Western European Time Location: The Altice Arena and FIL, Rossio dos Olivais, 1990-231 Lisbon, Portugal Presenter: Jack ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-31T08:03:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221031005044\/en\/1617359\/21\/ochre_bio_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Ochre Bio Announces Participation in Upcoming Conferences","datePublished":"2022-10-31T08:03:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/"},"wordCount":368,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221031005044\/en\/1617359\/21\/ochre_bio_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/","url":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/","name":"Ochre Bio Announces Participation in Upcoming Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221031005044\/en\/1617359\/21\/ochre_bio_logo.jpg","datePublished":"2022-10-31T08:03:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221031005044\/en\/1617359\/21\/ochre_bio_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221031005044\/en\/1617359\/21\/ochre_bio_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ochre-bio-announces-participation-in-upcoming-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ochre Bio Announces Participation in Upcoming Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50250"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50250\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}